The reasoning for the combination being more potent is a synergism in which anti-GD2 primes tumor cells for phagocytosis via the upregulation of surface proteins, while anti-CD47 prevents the tumor’s “don’t eat me” signals [121]. This evidence concerns the gene CD47 and neoplasm.